Mirena IUD Cases Selected for Initial Trial Pool in New Jersey Litigation

As a growing number of Mirena IUD lawsuits continue to move forward nationwide, a small group of cases pending in New Jersey state court are being prepared for early trial dates to help gauge how juries may respond to certain evidence and testimony that is likely to be repeated throughout the litigation.

Bayer Healthcare currently faces about 2,000 product liability lawsuits filed by women who experienced problems with Mirena IUD birth control, alleging that the small, T-shaped implant perforated the uterus, migrated to other areas of the body or caused other internal injuries.

More than 800 of the cases are currently pending in New Jersey state courts, which is where Bayer’s U.S. headquarters are based. The Mirena litigation in New Jersey has been centralized before Superior Court Judge Brian R. Martinotti in Bergen County, as part of a coordinated Multicounty Litigation, or MCL.

Did You Know?

AT&T Data Breach Impacts Millions of Customers

More than 73 million customers of AT&T may have had their names, addresses, phone numbers, Social Security numbers and other information released on the dark web due to a massive AT&T data breach. Lawsuits are being pursued to obtain financial compensation.

Learn More

According to an order (PDF) issued by Judge Martinotti last month, the parties were each directed to submit a list of eight cases by June 3, which will be included in an Initial Disposition Pool. It is expected that these 16 cases will go through case-specific discovery in preparation for the first state court Mirena trials in New Jersey, which will be scheduled at a future date.

Judge Martinotti indicates that cases selected for this Initial Disposition Pool may not be voluntarily dismissed by plaintiffs without prejudice, unless good cause shown for why they should be permitted to refile again at a future date. However, if any of the selected plaintiffs do decide to drop their case rather than moving forward, Bayer will be permitted to select a new case. If any of the selected cases are resolved through a Mirena settlement paid by the drug maker, plaintiffs will be permitted to select a replacement case of their choosing.

The first Mirena trials are not expected to begin until at least the second half of 2015.

Mirena IUD Problems

Bayer introduced Mirena in 2000, aggressively promoting the IUD as a hassle-free form of birth control. However, a growing number of women and their doctors have reported problems where the Mirena IUD migrated from its initial implant location, perforating the uterus and other organs, causing infections and abscesses, and leaving women unknowingly unprotected against the chance of pregnancy.

Since 2000, more than 70,000 adverse events have been filed with the FDA involving Mirena IUD problems, including at least 5,000 cases involving women who indicated that Mirena migrated out of place since 2008, and 1,322 reports where the Mirena IUD punctured the uterus.

Bayer has attempted to defend the cases, arguing that information about the risk of perforation was included on the warnings provided with the IUD. However, plaintiffs maintain that the previous warnings were vague and misleading, suggesting that the risk of injury only exists at the time of insertion. Most of the complaints involve women who found that the Mirena migrated spontaneously, often long after the IUD was successfully placed in the uterus.

In addition to the New Jersey state court litigation, Bayer also faces more than 500 cases that have been centralized in the federal court system before U.S. District Judge Cathy Seibel in the Southern District of New York, as part of a Multidistrict Litigation (MDL).

A small group of cases are also being prepared for early trial dates in the federal Mirena MDL, where a group of 24 cases have been selected as part of an “Initial Disposition Pool,” which will later be reduced to a group of 12 cases that will be prepared for the first trials.

If Bayer fails to settle Mirena lawsuits or otherwise resolve the litigation following these bellwether trials, the drug maker could face hundreds of individual trials in courts throughout the country.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

More Than 9,600 Join Suboxone Lawsuit Over Tooth Decay in MDL Filing
More Than 9,600 Join Suboxone Lawsuit Over Tooth Decay in MDL Filing (Posted today)

A bundled complaint of about 9,600 Suboxone lawsuits were filed in federal court on Friday, ahead of the two-year anniversary of the FDA requiring tooth decay label warnings on the opioid treatment film strips, which is also a deadline for filing a civil complaint in many states.

Lawyers Propose Direct Filing of Toxic Baby Food Lawsuits Over Autism, ADHD in Federal MDL
Lawyers Propose Direct Filing of Toxic Baby Food Lawsuits Over Autism, ADHD in Federal MDL (Posted today)

A federal judge has been asked to allow direct filing of future baby food lawsuits over autism and ADHD side effects with the MDL court, but the parties disagree over whether that order should allow multi-plaintiff complaints.

Social Media Mental Health Warnings Should Be Required To Protect Teens: U.S. Surgeon General
Social Media Mental Health Warnings Should Be Required To Protect Teens: U.S. Surgeon General (Posted 2 days ago)

U.S. Surgeon General says social media platforms like Facebook, Instagram and Tiktok should carry label warnings, alerting parents that youth who use the platforms face an increased risk of mental health side effects.